Merete Moeller Engelsen

Title: Merete Moeller Engelsen: Innovator in Xylanase Variants

Introduction

Merete Moeller Engelsen is a prominent inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of xylanase variants. Her work has implications for various industrial applications, showcasing her innovative spirit and dedication to scientific advancement.

Latest Patents

Engelsen holds a patent for "GH8 xylanase variants." This invention relates to isolated polypeptides that exhibit xylanase activity, as well as isolated polynucleotides that encode these polypeptides. The patent also encompasses nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides, along with methods for producing and utilizing the polypeptides. This patent highlights her expertise in enzyme technology and its applications.

Career Highlights

Merete Moeller Engelsen is associated with Novozymes A/S, a leading company in the field of biotechnology. Her role at Novozymes allows her to collaborate with other experts and contribute to innovative solutions in enzyme production and application.

Collaborations

Throughout her career, Engelsen has worked alongside notable colleagues, including Miguel Duarte Toscano and Henrik Lundkvist. These collaborations have further enriched her research and development efforts, leading to advancements in her field.

Conclusion

Merete Moeller Engelsen is a distinguished inventor whose work in xylanase variants has made a significant impact in biotechnology. Her contributions continue to influence the industry, demonstrating the importance of innovation in scientific research.